BioVie spin-off liver disease company Option Therapeutics (OPTN.US) reduces IPO size, lowers fundraising by 20% to $20 million

老虎证券2026/03/17 07:38

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This company, headquartered in Carson City, Nevada, now plans to raise $20 millions by issuing 1.8 million shares at a price range of $10 to $12. Previously, the company had applied to issue 2.3 million shares at the same price range. Based on the midpoint of the offering price range, Option Therapeutics' fundraising amount will be 20% less than previously expected.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BioVie spin-off liver disease company Option Therapeutics (OPTN.US) reduces IPO size, lowers fundraising by 20% to $20 million

You may also like

Crypto prices